AXA Shares Stable After Favorable Coverage Resumption by Deutsche Bank
AXA's stock has shown resilience following a positive coverage resumption by Deutsche Bank, which set a buy recommendation with a price target of 45 euros, indicating a potential upside of 11.7%. The stock's performance reflects broader positive sentiment in the European insurance sector.
Deutsche Bank Resumes Coverage with Positive Outlook
Deutsche Bank resumed coverage of AXA on Wednesday, January 7, with a buy recommendation and a price target set at 45 euros, representing an 11.7% potential increase from the closing price of 40.30 euros. This move is part of a broader analysis of the attractive European insurance sector by the German bank. Deutsche Bank expects a profit growth of about 9%, accompanied by a normalized dividend yield of 4.5%, supported by solvency ratios well above regulatory minimums and robust cash generation. After opening slightly lower by 0.59%, AXA's stock gradually recovered during the session, dipping below 40.30 euros in early trading before climbing to 40.86 euros by midday, thus registering a gain of 0.79%. The trading volumes remained modest with 0.15% of the capital traded. This positive reaction comes after a challenging week for the stock, which saw a decline of 2.04% over seven days, although the annual performance remains strong with a gain of 16.98%.
Technical Analysis and Future Prospects
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The price of 40.30 euros positions the stock slightly below its 200-day moving average of 40.38 euros, but remains above its 50-day moving average of 39.24 euros. This setup suggests a consolidation phase following the recent correction. The RSI at 53 indicates a neutral situation, with no overbought or oversold zones, allowing for movement in either direction. The Bollinger Bands, ranging from 38.78 euros in support to 42.10 euros in resistance, frame a relatively wide fluctuation space, reflecting contained volatility of 3.07% over a month. Breaking the resistance threshold at 41.20 euros would constitute a positive technical signal, paving the way towards the 45 euros target set by Deutsche Bank. Conversely, a decline below the support at 38.14 euros could trigger increased selling pressure. The insurer will publish its annual results for 2025 on February 26, a date closely watched by investors as analysts expect the continuation of the group's operational momentum in a context of favorable pricing in property and casualty insurance.
we expect underlying earnings of circa. Euro 8.6 billion with underlying EPS growth at the top end of the target range
Risks mentioned
Softening market conditions in large commercial P&C
Natural catastrophe exposure with normalized Nat Cat load of 4.5 points of combined ratio
Interest rate sensitivity with -50bp interest rates shock expected to result in -1pt impact in Solvency II ratio
Opportunities identified
Growth in Life & Savings segment driven by ageing populations and pressure on existing systems
Expansion in direct distribution channel with rising demand for affordable insurance and digital experiences
Deployment of AI across value chain with expected annual recurring benefits of €500-700m (pre-tax) by 2029
Outlook / guidance
Expected EBITDA: 500 millions d'euros
Expected net income: 8 600 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.